معرفی
Dennis Hendriksen, MSc, is a Researcher in the Department of Genetics at the University of Groningen's Faculty of Medical Sciences. His work focuses on developing bioinformatics solutions for clinical genomics and pharmacogenetics, with strong ties to the Lifelines population cohort and UMCG's genomic diagnostics infrastructure.
His research spans Bioinformatics, Genomics, and Pharmacogenetics, specializing in variant interpretation pipelines, oligonucleotide array applications, and open-source biomedical software development. Key contributions include the CAPICE pathogenicity prediction tool, MOLGENIS VIP diagnostic pipeline, and nanopore sequencing applications for neurological disorders.
Research trends show increasing focus on clinical implementation of genomic technologies, with recent work emphasizing cost-effective diagnostics, patient-friendly reporting, and first-tier sequencing applications. His 2025 publications demonstrate active leadership in translating research tools to clinical practice.
Hendriksen collaborates extensively within the University Medical Center Groningen ecosystem, particularly with the Swertz group on MOLGENIS platform development. His work appears in high-impact journals including American Journal of Human Genetics and Genome Medicine, with the 2019 MOLGENIS paper accumulating 73 Scopus citations.
